Your browser doesn't support javascript.
loading
Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer.
Mulkearns-Hubert, Erin E; Esakov Rhoades, Emily; Ben-Salem, Salma; Bharti, Rashmi; Hajdari, Nicole; Johnson, Sadie; Myers, Alex; Smith, Iris Nira; Bandyopadhyay, Smarajit; Eng, Charis; Downs, Erinn; Lathia, Justin D; Reizes, Ofer.
Afiliação
  • Mulkearns-Hubert EE; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Esakov Rhoades E; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio.
  • Ben-Salem S; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Bharti R; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Hajdari N; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Johnson S; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Myers A; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Smith IN; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Bandyopadhyay S; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Eng C; Molecular Biotechnology Core, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Downs E; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Lathia JD; Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Reizes O; Department of Cardiovascular and Metabolic Sciences, Cancer Impact Area, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
Mol Cancer Ther ; 23(1): 56-67, 2024 Jan 03.
Article em En | MEDLINE | ID: mdl-37703580
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinase 1 de Adesão Focal / Peptídeos Penetradores de Células / Neoplasias de Mama Triplo Negativas / Proteína Homeobox Nanog / Conexina 26 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinase 1 de Adesão Focal / Peptídeos Penetradores de Células / Neoplasias de Mama Triplo Negativas / Proteína Homeobox Nanog / Conexina 26 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2024 Tipo de documento: Article